Long-term impact of primary prophylaxis on joint status in patients with severe hemophilia A

BACKGROUND: Primary prophylaxis with factor VIII concentrates is the therapeutic gold standard for severe hemophilia A. Although this approach will change substantially with the use of nonsubstitutive therapies, the long-term effects of primary prophylaxis remain unclear. We present information on j...

Descripción completa

Detalles Bibliográficos
Autores principales: Meijón Ortigueira, María del Mar, Álvarez-Román, María Teresa, De La Corte Rodríguez, Hortensia, Butta Coll, Nora, Jiménez-Yuste, Víctor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986103/
https://www.ncbi.nlm.nih.gov/pubmed/36891521
http://dx.doi.org/10.1016/j.rpth.2022.100005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986103/
https://www.ncbi.nlm.nih.gov/pubmed/36891521
http://dx.doi.org/10.1016/j.rpth.2022.100005

Ejemplares similares